Gene · 730249
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DHODH as a targetable metabolic Achilles' heel for chemotherapy-resistant B-ALL. | Blood | 2026 | 41576347 | PubTator, text mining | PubMed |
| Protocol to study the role of endogenously produced itaconate using CRISPR-Cas9 technology in THP-1 cells. | STAR Protoc | 2026 | 41575844 | PubTator, text mining | PubMed |
| GPR176 enhances the epithelial‑mesenchymal transition in gastric cancer cells by activating the PI3K/AKT/mTOR signaling pathway. | Oncol Rep | 2026 | 41574720 | PubTator, text mining | PubMed |
| Chemoresistance: The hidden barrier in cancer treatment. | Cancer Pathog Ther | 2026 | 41550358 | PubTator, text mining | PubMed |
| Targeting opportunities presented by the pyrimidine biosynthesis pathway in Mycobacterium tuberculosis: a brief review. | Biochem Soc Trans | 2026 | 41527724 | PubTator, text mining | PubMed |
| Integrative Multi-Omics Analysis Prioritizes Candidate Genes for Essential Tremor and Reveals a Gap Between Computational Prediction and Experimental Validation. | Mov Disord | 2026 | 41178806 | PubTator, text mining | PubMed |
| Itaconate modulates myeloid inflammation in myocardial infarction via metabolic and structural reprogramming. | Genes Genomics | 2026 | 41166022 | PubTator, text mining | PubMed |
| Toward Trustworthy Multi-View Representation With Fine-Grained Explainability Embeddings. | IEEE Trans Med Imaging | 2026 | 40953435 | PubTator, text mining | PubMed |
| Metabolic and immunomodulatory control of type 2 diabetes via generating cellular itaconate reservoirs by inflammatory-targeting gene-therapy nanovesicles. | Trends Biotechnol | 2026 | 40925799 | PubTator, text mining | PubMed |
| CAD-driven pathways in HCC metastasis. | Hepatology | 2026 | 40105964 | PubTator, text mining | PubMed |
| CAD manipulates tumor intrinsic DHO/UBE4B/NF-κB pathway and fuels macrophage cross-talk, promoting HCC metastasis. | Hepatology | 2026 | 40073276 | PubTator, text mining | PubMed |
| Development of an untargeted metabolomics analytical protocol for fecal samples by liquid chromatography-mass spectrometry. | J Food Drug Anal | 2025 | 41525187 | PubTator, text mining | PubMed |
| Icaritin suppresses CAD-mediated liver cancer development by targeting miR-18b-5p in a xenograft mouse model. | Med Oncol | 2025 | 41452393 | PubTator, text mining | PubMed |
| Recurrent Breast Cancer Cells Depend on De novo Pyrimidine Biosynthesis to Suppress Ferroptosis. | bioRxiv | 2025 | 41332638 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals key genes and pathways involved in fruit abscission of Epimedium pubescens. | BMC Plant Biol | 2025 | 41331798 | PubTator, text mining | PubMed |
| Integrative bioinformatics and machine learning approach unveils potential biomarkers linking coronary atherosclerosis and glutamine metabolism-associated gene. | J Cardiothorac Surg | 2025 | 41327383 | PubTator, text mining | PubMed |
| In-silico identification of novel Cis-aconitate decarboxylase inhibitors as potential anti-inflammatory agents using molecular docking and dynamics. | Sci Rep | 2025 | 41309835 | PubTator, text mining | PubMed |
| IRG1/itaconate/NRF2/GSH axis in tumor-associated macrophages drives therapy resistance and immune evasion in BRCA1-deficient breast cancer. | bioRxiv | 2025 | 41279612 | PubTator, text mining | PubMed |
| CAD is Associated with Cancer Prognosis and Promotes Enzalutamide Resistance in Prostate Cancer. | Recent Pat Anticancer Drug Discov | 2025 | 41177787 | PubTator, text mining | PubMed |
| Tert-Butylhydroquinone (TBHQ) Suppresses LPS- and Poly (I:C)-Induced RAW 264.7 Macrophage Activation Through Reduced NF-κB/Type 1 Interferon and Enhanced Antioxidant-Related Pathways. | Toxics | 2025 | 41150582 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/730249/papers?page=5